Hepatorenal Syndrome in Decompensated Chronic Liver Disease: Diagnostic Criteria and Albumin Dosing
Is Absence of Hypotension Mandatory for HRS Diagnosis?
No, the absence of hypotension is NOT a mandatory diagnostic criterion for hepatorenal syndrome (HRS-AKI). In fact, hypotension can coexist with HRS, and when present, norepinephrine becomes the preferred vasoconstrictor over terlipressin 1.
The diagnostic criteria for HRS-AKI focus on:
- Cirrhosis with ascites
- AKI (Stage 2 or greater for treatment initiation)
- Lack of response to volume expansion with albumin (1 g/kg for 48 hours, max 100 g/day)
- Exclusion of other causes (shock, nephrotoxins, structural kidney disease)
- No improvement after diuretic withdrawal and treatment of precipitating factors 1, 2
The key distinction: If the patient is in shock with hypotension, norepinephrine should be used as the vasoconstrictor rather than terlipressin 1. This reflects that hypotension doesn't exclude HRS—it simply changes your therapeutic approach.
Albumin Dosing for HRS-AKI with Hypotension
Initial Volume Challenge (Diagnostic Phase)
For the initial diagnostic volume challenge: 1 g/kg body weight daily for 2 consecutive days (maximum 100 g/day) 1, 2. This is given to rule out volume-responsive AKI before diagnosing HRS-AKI.
Treatment Phase (After HRS-AKI Diagnosis)
Once HRS-AKI is confirmed and vasoconstrictors are initiated: 20-40 g/day of albumin 1. This is a dramatic reduction from the initial loading dose and represents the maintenance dosing during vasoconstrictor therapy.
Critical caveat: Recent evidence shows that excessive albumin (>50 g/day) does not improve outcomes and may increase risk of volume overload and respiratory complications 3, 4, 5. The 2024 AASLD guidance acknowledges that "the optimal duration of albumin administration in the setting of HRS treated with vasoconstrictors remains unclear" 1.
Infusion Duration and Method
How Many Hours?
The guidelines do not specify exact infusion duration per dose. However, based on FDA labeling and clinical practice 6:
- Albumin 25% solution should be infused slowly to avoid circulatory overload
- Typical infusion rates: 1-2 mL/minute for 25% albumin
- For a 100g dose (400 mL of 25% albumin): approximately 3-6 hours
- Faster rates risk pulmonary edema, especially in cirrhotic patients who are particularly sensitive to volume overload 6
Continuous vs. Intermittent?
Intermittent dosing is standard practice. The albumin is given as discrete infusions (e.g., 50g twice daily or 40g once daily), not as continuous infusion 1, 7, 8.
Practical Algorithm for Albumin Administration in HRS-AKI
Step 1: Initial Volume Challenge (Days 1-2)
- Give 1 g/kg/day (max 100 g/day) for 2 consecutive days
- Infuse over 3-6 hours per dose
- Monitor for volume overload (pulmonary edema, respiratory distress)
- Assess response: If creatinine improves, diagnosis is volume-responsive AKI, not HRS
Step 2: If HRS-AKI Confirmed (Day 3 onward)
- Reduce to 20-40 g/day albumin
- Initiate vasoconstrictors:
- Continue until:
- Creatinine clearance >40 mL/min OR
- Serum creatinine <1.5 mg/dL OR
- Liver transplantation
Step 3: Monitoring During Treatment
- Target MAP increase to enable renal perfusion 3
- Watch for volume overload (especially with albumin >50 g/day) 4
- Consider diuretics if volume overload develops 3
- CVP monitoring may guide albumin dosing in select cases 7
Critical Pitfalls to Avoid
Don't continue high-dose albumin (1 g/kg) beyond the initial 48-hour diagnostic period. This increases complications without improving outcomes 3, 4, 5.
Don't infuse albumin too rapidly. Cirrhotic patients are exquisitely sensitive to volume overload. Infuse 25% albumin at 1-2 mL/min maximum 6.
Don't use vasoconstrictors for Stage 1 AKI. Current guidelines only recommend vasoconstrictors for Stage 2 or greater HRS-AKI 1.
Don't miss infection as a precipitant. Treat bacterial infections (especially SBP) aggressively with antibiotics plus albumin, as this can prevent progression to HRS-AKI 1, 9.
Don't forget that liver transplantation is the definitive treatment. All HRS-AKI patients who are transplant candidates should be referred immediately 1.
Special Consideration: Hypotensive HRS-AKI Patients
For patients with HRS-AKI AND hypotension/shock:
- Norepinephrine is preferred over terlipressin 1
- Albumin dosing remains 20-40 g/day during vasoconstrictor therapy
- These patients require ICU-level monitoring
- Continuous RRT is preferable to intermittent if hemodynamically unstable 1
The presence of hypotension doesn't change the albumin dosing strategy—it changes your choice of vasoconstrictor and level of care required.